Search results
Results from the WOW.Com Content Network
Marijuana legalization doesn't appear to be on the horizon anytime soon. ... The last time Tilray's stock finished a year in positive territory was back in 2018, when its shares jumped by more ...
Tilray Brands (NASDAQ: TLRY) shares still aren't delivering on what investors may have hoped for, falling by 25% during the past 12 months. Tilray isn't the same company it was a couple of years ...
Tilray (TLRY) stock is trending higher on hopes of marijuana legalization in the United States The company has focus on recreational as well as medicinal cannabis with presence in high-growth ...
Image Source: Getty Images. A diversified consumer goods powerhouse. Tilray Brands is evolving beyond its roots as a pure-play cannabis company. Through strategic acquisitions, Tilray has built a ...
This worse-than-expected news is not necessarily a sign to buy the dip.
Overall, Tilray stock scores a Hold consensus rating based on 1 Buy, 8 Holds, and 1 Sell. The average analyst price target of $24.29 implies an upside potential of about 33% from current levels.
In the budding cannabis industry, there will be winners and losers. And for one-time heavyweight contender Tilray (NASDAQ:TLRY), a mixed earnings report has delivered another blow. But don't think ...
Shares of Tilray (TLRY) fell more than 17% on Tuesday after its post-IPO lockup period expired, allowing early investors in the Canadian marijuana company to cash out of their positions for the ...